Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.75
Delayed Data
As of Dec 09
 +0.01 / +0.27%
Today’s Change
2.85
Today|||52-Week Range
16.65
-76.08%
Year-to-Date
Celldex Therapeutics, Inc.'s Biggest Win in 2016
12:14pm / MotleyFool.com - Paid Partner Content
Why You Should (and Shouldn't) Buy Celldex Therapeutics, Inc.
Dec 06 / MotleyFool.com - Paid Partner Content
Is Celldex Therapeutics (CLDX) Stock a Solid Choice Right Now?
Dec 07 / Zacks.com - Paid Partner Content
The Worst Biotech Stocks of 2016
Dec 02 / MotleyFool.com - Paid Partner Content
Why Celldex Rallied 22% In November
Dec 07 / MotleyFool.com - Paid Partner Content
Down 11.7%: Is Celldex Therapeutics Now a Buy?
Nov 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.74
Today’s open3.78
Day’s range3.72 - 3.89
Volume1,606,563
Average volume (3 months)2,394,973
Market cap$379.7M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
IMMUImmunomedics Inc+0.06+1.65%
LNTHLantheus Holdings In...+0.15+1.61%
OXFDOxford Immunotec Glo...+0.27+1.84%
VCYTVeracyte Inc-0.09-1.19%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts


Search for Jobs